Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial

Highlights • Women have a higher risk for anthrax vaccine adsorbed (AVA)-associated injection site AEs. • We analyzed data from the CDC AVA human clinical trial for 8 injection site AEs. • Female and non-black participants had a higher proportion of AVA-associated AEs. • Female and non-black partici...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 32; no. 28; pp. 3548 - 3554
Main Authors Pondo, Tracy, Rose, Charles E, Martin, Stacey W, Keitel, Wendy A, Keyserling, Harry L, Babcock, Janiine, Parker, Scott, Jacobson, Robert M, Poland, Gregory A, McNeil, Michael M
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier 12.06.2014
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • Women have a higher risk for anthrax vaccine adsorbed (AVA)-associated injection site AEs. • We analyzed data from the CDC AVA human clinical trial for 8 injection site AEs. • Female and non-black participants had a higher proportion of AVA-associated AEs. • Female and non-black participants also had higher anti-PA IgG concentrations. • Antibody responses to other vaccines may also vary by gender and race.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2014.04.025